My blood is toxic to vampires . . . If there's one thing I want, it's to get off this iceberg. I'm thinking college on the East Coast. ANYWHERE besides Alaska. Then a near-fatal car wreck changes everything. Government agents jump in and save my life in exchange for my services as a vampire hunter. Did they just say vampires? Yep. And they're not the kind that sparkle. They're rabid, disgusting, rude . . . and way too suave. Those are the ones I really have to watch out for. A knife isn't my only weapon. My rare blood type sends vampires into temporary paralysis right before I have to finish the job by hand. Basically, I'm a glorified chew toy. Now I'm stuck with an overzealous partner, a group of suck junkies, and a maddening attraction to Mr. Joe Cool, dresses all in black, Fane Donado. Clearly, he's keeping secrets of his own. The old Aurora is gone forever. Destroyed in the wreckage. I don’t know who I am anymore, only that I suddenly have intense cravings and a V.I.P. pass into Alaska’s underworld. If vampires found out who I worked for it would be lights out forever. In the meantime, I have some undead ass to kick so long as it doesn't kick mine first. Fans of young adult dark fantasy, vampires, action, and forbidden romance will devour this story. Get your copy and start reading today!

NEW YORK TIMES BESTSELLING SERIES • The squad you love is out of time. Prepare for the thrilling finale in the epic, best-selling Aurora Cycle series about a band of unlikely heroes who just might be the galaxy's last hope for survival. Is this the end? What happens when you ask a bunch of losers, discipline cases, and misfits to save the galaxy from an ancient evil? The ancient evil wins, of course. Wait. . . . Not. So. Fast. When we last saw Squad 312, they working together seamlessly (aka, freaking out) as an intergalactic battle raged and an ancient superweapon threatened to obliterate Earth. Everything went horribly wrong, naturally. But as it turns out, not all endings are endings, and the team has one last chance to rewrite theirs. Maybe two. It's complicated. Cue Zila, Fin, and Scarlett (and MAGELLAN!): making friends, making enemies, and making history? Sure, no problem Cue Tyler, Kal, and Auri: uniting with two of the galaxy’s most hated villains? Um, okay. That, too. Actually saving the galaxy, though? Now that will take a miracle.

Twins, Ryan and Aurora, are abandoned by their drug addict mother at a young age and forced to live with their abusive father Marc Smith. Brutal injuries land Aurora in hospital and Marc Smith in prison, resulting in the children being put up for adoption. The mysterious killings of their beloved adoptive parents brings about a revelation of their true nature, by a close relative. Will they be able to live up to this incredible new life? Will their true nature be enough to give them the strength needed to survive the big task?

When a public defender is targeted by a killer, a smalltown sheriff is determined to keep her safe in this Christian romantic suspense novel. When Tennessee public defender Aurora Daniels becomes the target of someone seeking their own twisted justice, Sheriff Beckett Marsh is the only one who can rescue her. In her line of work, Aurora has angered plenty of people in town—and in her past. And while Beckett constantly clashes with the feisty lawyer professionally, it’s his duty to protect and serve. Now guarding Aurora 24/7 is Beckett’s sole assignment. He may not have been able to save his fiancée from a dangerous felon, but he’ll do whatever it takes to keep Aurora alive. Even if working with her to catch and convict this ruthless killer puts his heart in the crosshairs.

This book provides an unprecedented overview of "Targeted Therapies" for acute myeloid leukemias. It aims at an almost comprehensive coverage of the diverse therapeutic strategies that have been developed during the last decade and are now being evaluated in early clinical trials. Paired and authoritative chapters by leading research scientists and clinicians explain basic concepts and clinical translation of topics that include the underlying genetic and proteomic abnormalities of AML, the development of novel nucleoside analogues, the roles of microRNAs, apoptosis regulators Bcl-2 and p53 and of critical cell signaling proteins such as PIM, FLT3, Raf/MEK, PI3K/AKT/mTOR and aurora kinases. Chapters on epigenetic mechanisms, nuclear receptors, cell surface antigens, the hypoxic leukemia microenvironment, stem cells and leukemia metabolism provide insights into leukemia cell vulnerabilities. Cell therapies utilizing T-, NK- and mesenchymal stem cells and progress in hematopoietic transplantation strategies round up this overview of the multi-dimensional therapeutic landscape in which leukemia specialists develop treatment strategies that are expected to make "leukemia history" in the near future.